AbbVie, Alphabet-Backed Calico Extend Aging Collaboration by $1B, Three Years

AbbVie and Alphabet-backed Calico said today they will contribute an additional $1 billion to—and extend by three years—their nearly four-year-old collaboration to develop and commercialize new treatments for aging and age-related diseases, including neurodegeneration and cancer.AbbVie and Alphabet, Google’s parent company, said they agreed to chip in $500 million toward the extended collaboration, with Calico continuing to pursue discovery-stage research and development, and A